PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: GlobeNewswire
MENLO PARK, Calif. & BERLIN, April 21, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a premier developer of sequencing solutions, and Lucid Genomics GmbH, a provider of cutting-edge bioinformatics software for clinical and research genomics, today announced that Lucid Genomics has joined the PacBio Compatible partner program as a solution for tertiary analysis of data generated on PacBio long-read sequencing instruments. Tertiary analysis represents a critical step in the sequencing workflow, where processed genomic data is translated into biological and potentially clinically relevant insights. Tertiary analysis enables streamlined annotation, interpretation, and reporting of genomic variants to help derive value from sequencing data and better understand variation underlying human disease. This collaboration highlights the interoperability of Lucid Genomics’ analysis platform with PacBio’s HiFi sequencing technology, enabling scientists and clinical researchers to transform lo
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- PacBio to Report First Quarter 2026 Financial Results on May 7, 2026GlobeNewswire
- PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor SamplesGlobeNewswire
- Pacific Biosciences of California (PACB) had its price target lowered by Barclays PLC from $1.50 to $1.00. They now have an "underweight" rating on the stock.MarketBeat
- Pacific Biosciences (PACB) Garnering Attention Amid Involvement in Trillion Gene Atlas Program [Yahoo! Finance]Yahoo! Finance
- Assembling Over 1,000 Human Genomes Affordably: New Method Powers Medicine's Future [Yahoo! Finance]Yahoo! Finance
PACB
Earnings
- 2/12/26 - Beat
PACB
Sec Filings
- 4/10/26 - Form 4
- 4/3/26 - Form 4
- 4/1/26 - Form 144
- PACB's page on the SEC website